Treatment of chronic hepatitis C: can complexity pave the way towards elimination?
- PMID: 28416220
- DOI: 10.1016/S2468-1253(17)30085-7
Treatment of chronic hepatitis C: can complexity pave the way towards elimination?
Comment on
-
Ombitasvir, paritaprevir, and ritonavir plus dasabuvir for 8 weeks in previously untreated patients with hepatitis C virus genotype 1b infection without cirrhosis (GARNET): a single-arm, open-label, phase 3b trial.Lancet Gastroenterol Hepatol. 2017 Jul;2(7):494-500. doi: 10.1016/S2468-1253(17)30071-7. Epub 2017 Apr 14. Lancet Gastroenterol Hepatol. 2017. PMID: 28416221 Clinical Trial.
Similar articles
-
Micro-elimination of hepatitis C virus infection in β-Thalassaemia major patients: Positively moving towards the World Health Organisation 2030 eradication goal.Dig Liver Dis. 2019 Apr;51(4):568-569. doi: 10.1016/j.dld.2019.01.001. Epub 2019 Jan 14. Dig Liver Dis. 2019. PMID: 30691776 No abstract available.
-
Are we nearing the end in the fight against hepatitis C?Expert Rev Gastroenterol Hepatol. 2017 Jun;11(6):499-500. doi: 10.1080/17474124.2017.1309287. Epub 2017 Mar 28. Expert Rev Gastroenterol Hepatol. 2017. PMID: 28335650 No abstract available.
-
Emerging complexities with hepatitis C virus direct-acting antiviral regimens: Less is still Way more.Hepatology. 2016 Nov;64(5):1401-1403. doi: 10.1002/hep.28832. Epub 2016 Sep 30. Hepatology. 2016. PMID: 27635632 No abstract available.
-
Development of boceprevir: a first-in-class direct antiviral treatment for chronic hepatitis C infection.Ann N Y Acad Sci. 2013 Jul;1291:69-76. doi: 10.1111/nyas.12218. Ann N Y Acad Sci. 2013. PMID: 23859802 Review.
-
Hepatitis C Virus and Antiviral Drug Resistance.Gut Liver. 2016 Nov 15;10(6):890-895. doi: 10.5009/gnl15573. Gut Liver. 2016. PMID: 27784846 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources